These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The Development of Whole Sporozoite Vaccines for Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK Front Immunol; 2018; 9():2748. PubMed ID: 30619241 [TBL] [Abstract][Full Text] [Related]
23. Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria. Drew DR; Hodder AN; Wilson DW; Foley M; Mueller I; Siba PM; Dent AE; Cowman AF; Beeson JG PLoS One; 2012; 7(12):e51023. PubMed ID: 23227229 [TBL] [Abstract][Full Text] [Related]
24. Whole sporozoite immunization with Plasmodium falciparum strain NF135 in a randomized trial. van der Boor SC; Alkema M; van Gemert GJ; Teelen K; van de Vegte-Bolmer M; Walk J; van Crevel R; de Mast Q; Ockenhouse CF; Sauerwein RW; McCall MBB BMC Med; 2023 Apr; 21(1):137. PubMed ID: 37024868 [TBL] [Abstract][Full Text] [Related]
25. Within-population genetic diversity of Plasmodium falciparum vaccine candidate antigens reveals geographic distance from a Central sub-Saharan African origin. Tanabe K; Mita T; Palacpac NM; Arisue N; Tougan T; Kawai S; Jombart T; Kobayashi F; Horii T Vaccine; 2013 Feb; 31(9):1334-9. PubMed ID: 23295064 [TBL] [Abstract][Full Text] [Related]
29. Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes. Sedegah M; Peters B; Hollingdale MR; Ganeshan HD; Huang J; Farooq F; Belmonte MN; Belmonte AD; Limbach KJ; Diggs C; Soisson L; Chuang I; Villasante ED PLoS One; 2016; 11(10):e0163026. PubMed ID: 27695088 [TBL] [Abstract][Full Text] [Related]
30. Controlled Human Malaria Infection with Graded Numbers of Langenberg MCC; Wammes LJ; McCall MBB; Bijker EM; van Gemert GJ; Graumans W; van de Vegte-Bolmer MG; Teelen K; Hermsen CC; Koelewijn R; van Hellemond JJ; van Genderen PJJ; Sauerwein RW Am J Trop Med Hyg; 2018 Sep; 99(3):709-712. PubMed ID: 30014816 [TBL] [Abstract][Full Text] [Related]
31. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development. Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785 [TBL] [Abstract][Full Text] [Related]
32. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine. Zeeshan M; Alam MT; Vinayak S; Bora H; Tyagi RK; Alam MS; Choudhary V; Mittra P; Lumb V; Bharti PK; Udhayakumar V; Singh N; Jain V; Singh PP; Sharma YD PLoS One; 2012; 7(8):e43430. PubMed ID: 22912873 [TBL] [Abstract][Full Text] [Related]
33. Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study. Stanisic DI; Fink J; Mayer J; Coghill S; Gore L; Liu XQ; El-Deeb I; Rodriguez IB; Powell J; Willemsen NM; De SL; Ho MF; Hoffman SL; Gerrard J; Good MF BMC Med; 2018 Oct; 16(1):184. PubMed ID: 30293531 [TBL] [Abstract][Full Text] [Related]